Onconetix, Inc. Common Stock

ONCONASDAQ • USD
ThemeHealthcare - Oncology›Cancer Diagnostics & Biomarkers
1.03 USD
↘ 0.01 (0.96%)AT CLOSE (11:59 AM EDT)
1.01
↘ 0.02 (1.94%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
1.01
↘ 0.02 (1.94%)
🔴Market: CLOSED
Open?$0.97
High?$1.05
Low?$0.92
Prev. Close?$1.04
Volume?529.0K
Avg. Volume?10.6M
VWAP?$0.98
Rel. Volume?0.05x
Bid / Ask
Bid?$0.84 × 100
Ask?$1.25 × 100
Spread?$0.41
Midpoint?$1.05
Valuation & Ratios
Market Cap?1.2M
Shares Out?1.1M
Float?581.5K
Float %?83.9%
P/E Ratio?N/A
P/B Ratio?0.10
EPS?-$8.75
Dividend?0.00%
Ex-Dividend?N/A

ONCO is currently priced at $1.03. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, ONCO appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Themes
Healthcare - Oncology›Cancer Diagnostics & Biomarkers
Employees
2
Market Cap
1.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.onconetix.com
Listed
2022-02-18
Address
201 E. FIFTH STREET
CINCINNATI, OH 45202
Phone: 513-620-4101
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
65
Short Sent.?
83
Piotroski F-Score?1/9Weak
Altman Z-Score?-15.85Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?9.69%Elevated
Short Interest?56.4K
Days to Cover?1.0
Free Float581.5K
Avg Daily Volume909.3K
Settlement Date2026-05-15
Financial Health
Current Ratio?1.41Adequate
Quick Ratio?1.37Adequate
Cash Ratio?1.21Strong
Debt/Equity?0.02Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.10CHEAP▾
P/S?
Peers
100
S&P
76
1.61CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.3CHEAP▾
EV/Sales?
S&P
97
-3.11CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-85.4%WEAK▾
ROA?
S&P
3
-67.6%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-2288025
Fundamentals ratios updated end of day
MarketsMoversWatchlist